Pharma Mar (FRA:PMRA) FFO


FRA:PMRA Pharma Mar SA FRA:PMRA
83 GF Score
Price €72.15
GF Value €83.37
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PMRA
83GF Score
Pharma Mar SA FRA:PMRA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharma Mar (FRA:PMRA) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of €72.15 is trading 13.5% below its estimated GF Value™ of €83.37. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for FRA:PMRA:

  • FFO:
  • GF Value™: €83.37 vs. price of €72.15 (13.5% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the FRA:PMRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
83GF Score

Get the complete analysis for FRA:PMRA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€72.15
Price
€83.37
GF Value